Enstilar and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Enstilar (betamethasone dipropionate; calcipotriene), especially for people who are male, 50-59 old, also take Inflectra, and have Psoriasis.

The phase IV clinical study analyzes which people have Weight increased when taking Enstilar. It is created by eHealthMe based on reports of 1,668 people who have side effects when taking Enstilar from the FDA, and is updated regularly.

What is Enstilar?

Enstilar has active ingredients of betamethasone dipropionate; calcipotriene. eHealthMe is studying from 1,673 Enstilar users. Check the latest studies of Enstilar.

What is Weight increased?

Weight increased is found to be associated with 2,887 drugs and 3,963 conditions by eHealthMe. Check the latest studies of Weight increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 19, 2026

1,668 people reported to have side effects when taking Enstilar.
Among them, 12 people (0.72%) have Weight increased.

Among these 12 people:

What is the gender of people who have Weight increased when taking Enstilar? *

female: 20 %
male: 80 %

What is the age of people who have Weight increased when taking Enstilar? *

What are other drugs people take besides Enstilar? *

What are other side effects people have besides Weight increased? *

Psoriasis (immune-mediated disease that affects the skin): 6 people, 50.00%
Joint Pain: 6 people, 50.00%
Fatigue (feeling of tiredness): 4 people, 33.33%
Headache (pain in head): 4 people, 33.33%
Blood Pressure Fluctuation: 4 people, 33.33%
Dizziness: 4 people, 33.33%
Oropharyngeal Pain: 4 people, 33.33%
Skin Fragility (trauma-induced blisters and erosions of skin): 3 people, 25.00%
Ear Infection Fungal: 3 people, 25.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 25.00%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 10 people, 83.33%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 50.00%
Stress And Anxiety: 1 person, 8.33%
Immunodeficiency Common Variable: 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Diabetes Insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function): 1 person, 8.33%
Depression: 1 person, 8.33%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Enstilar and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enstilar:

Enstilar (1,673 reports)

Weight increased treatments and more:

Weight increased (279,370 reports)

How severe was Weight increased and when was it recovered:

Weight increased in Enstilar

Expand to all the drugs that have ingredients of betamethasone dipropionate; calcipotriene:

Weight increased and drugs with ingredients of betamethasone dipropionate; calcipotriene

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Enstilar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,887 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,963 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone dipropionate; calcipotriene (the active ingredients of Enstilar) and Enstilar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.